{
    "nctId": "NCT04669301",
    "briefTitle": "Memory and Attention Adaptation Training-Geriatrics (MAAT-G) Phase II",
    "officialTitle": "Mitigating Cancer-Related Cognitive Impairment in Older Adults With Breast Cancer Receiving Chemotherapy: Memory and Attention Adaptation Training-Geriatrics (MAAT-G): A Randomized Pilot Study",
    "overallStatus": "COMPLETED",
    "conditions": "Cancer-related Problem/Condition, Cognitive Impairment",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "SUPPORTIVE_CARE",
    "enrollmentCount": 85,
    "primaryOutcomeMeasure": "Functional Assessment of Cancer Therapy-Cognition (FACT-COG)",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Have a diagnosis of invasive breast cancer\n* Planned to receive systemic therapy for breast cancer or actively receiving systemic therapy for breast cancer with two additional cycles remaining.\n* Be age 65 or older\n* Able to provide informed consent\n* Able to read and understand English (or possess a designated health care proxy that can do the same that was designated prior to the patient losing decision-making capabilities)\n\nExclusion Criteria:\n\n* Have surgery planned within 3 months of consent\n* Patients who do not have decision-making capacity (decisionally or cognitively impaired) AND do NOT have a previously designated health care proxy (established prior to their cognitive impairment) available to sign consent\n* Patients with breast cancer receiving endocrine therapy as their only systemic therapy will not be eligible.",
    "sex": "ALL",
    "minimumAge": "65 Years",
    "stdAges": "OLDER_ADULT"
}